Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Obagi Medical Products, Inc. (OMPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/26/2013 8-K Quarterly results
03/20/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Odysseus Acquisition Corp., Valeant Pharmaceuticals International, Inc. and Obagi Medical Products, Inc",
"Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. For $19.75 per Share in Cash"
03/14/2013 8-K Quarterly results
Docs: "Obagi Medical Products Reports Fourth Quarter and Year-End 2012 Financial Results"
11/01/2012 8-K Quarterly results
Docs: "Obagi Medical Products Reports Third Quarter 2012 Earnings; Company Provides Update to Key Initiatives --Conference Call To Be Held at 4:30 PM EDT Today--"
10/29/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "CONFIDENTIAL SETTLEMENT AND RELEASE"
08/16/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Obagi Medical Products Appoints Mark Taylor as Senior Vice President Corporate Development and Investor Relations"
08/02/2012 8-K Quarterly results
Docs: "OBAG MEDICAL PRODUCTS EARNINGS RELEASE"
08/02/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "KRISTINA M. LESLIE JOINS BOARD OF DIRECTORS OF OBAGI MEDICAL PRODUCTS"
07/10/2012 8-K Form 8-K - Current report
06/06/2012 8-K Termination of a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Submission of Matters t...
05/25/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "AMENDMENT NO.1 TO RIGHTS AGREEMENT"
05/03/2012 8-K Quarterly results
Docs: "OBAGI MEDICAL PRODUCTS EARNINGS RELEASE"
04/18/2012 8-K Form 8-K - Current report
03/13/2012 8-K Form 8-K - Current report
03/08/2012 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "OBAGI MEDICAL PRODUCTS EARNINGS RELEASE 123111"
12/23/2011 8-K Form 8-K - Current report
11/09/2011 8-K Form 8-K - Current report
08/04/2011 8-K Form 8-K - Current report
06/07/2011 8-K Form 8-K - Current report
05/12/2011 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "COMERICA AMEDMENT"
05/05/2011 8-K Form 8-K - Current report
03/10/2011 8-K Form 8-K - Current report
11/19/2010 8-K Form 8-K - Current report
11/15/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "PRESS RELEASE FOR STOCK PURCHASE AGREEMENT",
"Stock Purchase Agreement by and among Obagi Medical Products, Inc., Stonington Capital Appreciation 1994 Fund, L.P. and The Zein and Samar Obagi Family Trust"
11/04/2010 8-K Quarterly results
Docs: "EARNINGS RELEASE Q3 2010"
10/26/2010 8-K Form 8-K - Current report
10/15/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Obagi Medical Products Announces Changes to its Senior Management October 11, 2010 - Obagi Medical Products, Inc. announced today that President and Chief Executive Officer Steven R. Carlson has resigned, effective immediately, from those posts and from the Company’s Board of Directors. The Company also announced that Mr. Albert F. Hummel, a Director, has been appointed as interim President and Chief Executive Officer. Mr. Hummel has been a Director of Obagi since 2005. Board Chairman Albert J. Fitzgibbons said, “The Board thanks Steve Carlson for his more than five years of service, during which time the Company completed its successful initial public offering, developed and introduced several new products and saw its annual sales revenues grow from $56 million to $104 million.” Mr. Fitzg..."
09/09/2010 8-K Form 8-K - Current report
08/05/2010 8-K Form 8-K - Current report
06/09/2010 8-K Submission of Matters to a Vote of Security Holders
03/11/2010 8-K Form 8-K - Current report
01/11/2010 8-K Form 8-K - Current report
11/05/2009 8-K Quarterly results
Docs: "OBAGI MEDICAL PRODUCTS, PRESS RELEASE NOVEMBER 5, 2009"
08/06/2009 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy